Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients

Clinical and Experimental Nephrology

Volumn 15, Issue 1, 2011, Pages 79-85

  Tone, Atsuhito ^a   Shikata, Kenichi ^b   Nakagawa, Koichi ^c   Hashimoto, Masaaki ^c   Makino, Hirofumi ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Fukuyama National Hospital   (Japan)

Author keywords

Clarithromycin; Diabetic nephropathy; Macrolide; MCP 1; Microinflammation

Indexed keywords

C REACTIVE PROTEIN; CLARITHROMYCIN; CREATININE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1;

AGED; ALBUMINURIA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; HUMAN; INTERCELLULAR ADHESION MOLECULE 1 BLOOD LEVEL; INTERLEUKIN 18 URINE LEVEL; MALE; MICROALBUMINURIA; MONOCYTE CHEMOTACTIC PROTEIN 1 URINE LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; URINE LEVEL;

AGED; ANIMALS; ANTI-BACTERIAL AGENTS; CHEMOKINE CCL2; CLARITHROMYCIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PILOT PROJECTS; PROTEINURIA; RATS;

EID: 79952184907     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0357-1     Document Type: Article

References (41)

1. HH Parving H Lehnert J Brochner-Mortensen R Gomis S Andersen P Arner 2001 The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 870 878 1:CAS:528:DC%2BD3MXntlelsLY%3D 10.1056/NEJMoa011489 11565519
2. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1456 1462 1:STN:280: DyaK2c%2FhvFKitQ%3D%3D 10.1056/NEJM199311113292004 8413456 (Pubitemid 23335891)
3. K Hiragushi H Sugimoto K Shikata T Yamashita N Miyatake Y Shikata, et al. 2001 Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes Diabetes Res Clin Pract 53 149 159 1:CAS:528:DC%2BD3MXls1aqsbc%3D 10.1016/S0168-8227(01)00260-1 11483230 (Pubitemid 32727732)
4. D Koya MR Jirousek YW Lin H Ishii K Kuboki GL King 1997 Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats J Clin Invest 100 115 126 1:CAS:528:DyaK2sXksVOhsr4%3D 10.1172/JCI119503 9202063 (Pubitemid 27311249)
5. G Pugliese F Pricci G Romeo F Pugliese P Mene S Giannini, et al. 1997 Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism Diabetes 46 1881 1887 1:CAS:528:DyaK2sXntVKitbY%3D 10.2337/diabetes.46.11.1881 9356040 (Pubitemid 27456425)
6. CW Yang H Vlassara EP Peten CJ He GE Striker LJ Striker 1994 Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease Proc Natl Acad Sci USA 91 9436 9440 1:CAS:528:DyaK2cXmt1Ort7k%3D 10.1073/pnas.91.20.9436 7937785 (Pubitemid 24297929)
7. T Furuta T Saito T Ootaka J Soma K Obara K Abe, et al. 1993 The role of macrophages in diabetic glomerulosclerosis Am J Kidney Dis 21 480 485 1:STN:280:DyaK3s3ls1Sntw%3D%3D 8488815 (Pubitemid 23160508)
8. C Sassy-Prigent D Heudes C Mandet MF Belair O Michel B Perdereau, et al. 2000 Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats Diabetes 49 466 475 1:CAS:528:DC%2BD3cXlsFCqsro%3D 10.2337/diabetes.49.3. 466 10868970 (Pubitemid 30131794)
9. F Chow E Ozols DJ Nikolic-Paterson RC Atkins GH Tesch 2004 Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury Kidney Int 65 116 128 1:CAS:528:DC%2BD2cXmt1Wjtg%3D%3D 10.1111/j.1523-1755.2004.00367.x 14675042 (Pubitemid 38037496)
10. N Banba T Nakamura M Matsumura H Kuroda Y Hattori K Kasai 2000 Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy Kidney Int 58 684 690 1:CAS:528:DC%2BD3cXlvFagsrY%3D 10.1046/j.1523-1755.2000. 00214.x 10916091 (Pubitemid 30620017)
11. T Wada K Furuichi N Sakai Y Iwata K Yoshimoto M Shimizu, et al. 2000 Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy Kidney Int 58 1492 1499 1:CAS:528:DC%2BD3cXntlyltb4%3D 10.1046/j.1523-1755.2000.00311.x 11012884
12. M Ruiz-Ortega C Bustos MA Hernandez-Presa O Lorenzo JJ Plaza J Egido 1998 Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis J Immunol 161 430 439 1:CAS:528: DyaK1cXktVynu7c%3D 9647253 (Pubitemid 28285552)
13. S Kato VA Luyckx M Ots KW Lee F Ziai JL Troy, et al. 1999 Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats Kidney Int 56 1037 1048 1:CAS:528:DyaK1MXlvF2gu7s%3D 10.1046/j.1523-1755.1999.00643.x 10469372 (Pubitemid 29411731)
14. M Yamaya H Sasaki 2003 Rhinovirus and asthma Viral Immunol 16 99 109 1:CAS:528:DC%2BD3sXks12qsr0%3D 10.1089/088282403322017857 12828863 (Pubitemid 36734788)
15. T Miyanohara M Ushikai S Matsune K Ueno S Katahira Y Kurono 2000 Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts Laryngoscope 110 126 131 1:STN:280:DC%2BD3c7htVKnug%3D%3D 10.1097/00005537- 200001000-00023 10646728 (Pubitemid 30046658)
16. A Tone K Shikata M Sasaki S Ohga K Yozai S Nishishita, et al. 2005 Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats Diabetologia 48 2402 2411 1:CAS:528: DC%2BD2MXht1Skt7jM 10.1007/s00125-005-1945-6 16231067 (Pubitemid 41618933)
17. K Hirata K Shikata M Matsuda K Akiyama H Sugimoto M Kushiro, et al. 1998 Increased expression of selectins in kidneys of patients with diabetic nephropathy Diabetologia 41 185 192 1:CAS:528:DyaK1cXosl2gtQ%3D%3D 10.1007/s001250050888 9498652 (Pubitemid 28088395)
18. N Miyatake K Shikata H Sugimoto M Kushiro Y Shikata S Ogawa, et al. 1998 Intercellular adhesion molecule 1 mediates mononuclear cell infiltration into rat glomeruli after renal ablation Nephron 79 91 98 1:CAS:528:DyaK1cXjtFGgsr8%3D 10.1159/000044997 9609468 (Pubitemid 28204044)
19. H Sugimoto K Shikata K Hirata K Akiyama M Matsuda M Kushiro, et al. 1997 Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation Diabetes 46 2075 2081 1:CAS:528:DyaK2sXnslGqtLc%3D 10.2337/diabetes.46.12.2075 9392499 (Pubitemid 27512099)
20. S Okada K Shikata M Matsuda D Ogawa H Usui Y Kido, et al. 2003 Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes Diabetes 52 2586 2593 1:CAS:528: DC%2BD3sXotVWhsb0%3D 10.2337/diabetes.52.10.2586 14514644 (Pubitemid 37210549)
21. H Usui K Shikata M Matsuda S Okada D Ogawa T Yamashita, et al. 2003 HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats Nephrol Dial Transpl 18 265 272 1:CAS:528:DC%2BD3sXisVClsrs%3D 10.1093/ndt/18.2.265 (Pubitemid 36181675)
22. T Ota T Takamura H Ando E Nohara H Yamashita K Kobayashi 2003 Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model Diabetologia 46 843 851 1:CAS:528:DC%2BD3sXkvFyjtrs%3D 10.1007/s00125-003-1099-3 12774163 (Pubitemid 36831414)
23. K Yozai K Shikata M Sasaki A Tone S Ohga H Usui, et al. 2005 Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions J Am Soc Nephrol 16 3326 3338 1:CAS:528:DC%2BD2MXht1Cnsr3O 10.1681/ASN.2004111011 16177002 (Pubitemid 46179336)
24. R Utimura CK Fujihara AL Mattar DM Malheiros IL Noronha R Zatz, et al. 2003 Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes Kidney Int 63 209 216 1:CAS:528:DC%2BD3sXmtV2huw%3D%3D 10.1046/j.1523-1755.2003.00736.x 12472785 (Pubitemid 35463923)
25. Y Kikuchi T Imakiire M Yamada T Saigusa T Hyodo N Hyodo, et al. 2005 Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats Nephrol Dial Transpl 20 1573 1581 1:CAS:528:DC%2BD2MXmsV2htL8%3D 10.1093/ndt/gfh888 (Pubitemid 41418579)
26. G Gruden G Setti A Hayward D Sugden S Duggan D Burt, et al. 2005 Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone J Am Soc Nephrol 16 688 696 1:CAS:528:DC%2BD2MXis12gu7s%3D 10.1681/ASN.2004030251 15677312 (Pubitemid 41725105)
27. CG Ihm JK Park SP Hong TW Lee BS Cho MJ Kim, et al. 1998 A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells Nephron 79 33 37 1:CAS:528:DyaK1cXjtFGhu7o%3D 10.1159/000044988 9609459 (Pubitemid 28204035)
28. T Morii H Fujita T Narita T Shimotomai H Fujishima N Yoshioka, et al. 2003 Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy J Diabetes Complicat 17 11 15 10.1016/S1056-8727(02) 00176-9 12505750 (Pubitemid 36042786)
29. H Ha MR Yu YJ Choi M Kitamura HB Lee 2002 Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells J Am Soc Nephrol 13 894 902 1:CAS:528: DC%2BD38XjtFSnsbk%3D 11912248 (Pubitemid 34274085)
30. FY Chow DJ Nikolic-Paterson FY Ma E Ozols BJ Rollins GH Tesch 2007 Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice Diabetologia 50 471 480 1:CAS:528:DC%2BD2sXitlSksQ%3D%3D 10.1007/s00125-006- 0497-8 17160673
31. B Amann R Tinzmann B Angelkort 2003 ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1 Diabetes Care 26 2421 2425 1:CAS:528:DC%2BD3sXmslOkuro%3D 10.2337/diacare.26.8.2421 12882873 (Pubitemid 36993337)
32. K Takebayashi S Matsumoto Y Aso T Inukai 2006 Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy J Clin Endocrinol Metab 91 2214 2217 1:CAS:528:DC%2BD28XlvVCgsbw%3D 10.1210/jc.2005-1718 16569732 (Pubitemid 43855008)
33. SY Han CH Kim HS Kim YH Jee HK Song MH Lee, et al. 2006 Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats J Am Soc Nephrol 17 1362 1372 1:CAS:528:DC%2BD28XkvVKrsLs%3D 10.1681/ASN.2005111196 16571782 (Pubitemid 43673416)
34. A Nakamura K Shikata M Hiramatsu T Nakatou T Kitamura J Wada, et al. 2005 Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes Diabetes Care 28 2890 2895 1:CAS:528:DC%2BD28XhsFE%3D 10.2337/diacare.28.12.2890 16306550 (Pubitemid 43942920)
35. Y Li A Azuma S Takahashi J Usuki K Matsuda A Aoyama, et al. 2002 Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice Chest 122 2137 2145 1:CAS:528:DC%2BD3sXlsF2gsA%3D%3D 10.1378/chest.122.6.2137 12475858 (Pubitemid 36051154)
36. W Ren XH Li BD Chen PH Wooley 2004 Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity J Orthop Res 22 21 29 1:CAS:528:DC%2BD3sXptlyhs7g%3D 10.1016/S0736-0266(03)00130-X 14656655 (Pubitemid 38035441)
37. B Wallwork W Coman A Mackay-Sim A Cervin 2004 Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis Laryngoscope 114 286 290 1:CAS:528:DC%2BD2cXosFShug%3D%3D 10.1097/00005537-200402000-00019 14755204 (Pubitemid 38182624)
38. F Enomoto R Kin T Kataoka Y Yamazaki H Yokoi M Fujimori, et al. 2003 Modulation of neutrophil adhesion to vascular endothelial cells in rat experimental otitis media treated with a macrolide Auris Nasus Larynx 30 247 251 10.1016/S0385-8146(03)00097-X 12927286 (Pubitemid 36960228)
39. T Kikuchi K Hagiwara Y Honda K Gomi T Kobayashi H Takahashi, et al. 2002 Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors J Antimicrob Chemother 49 745 755 1:CAS:528:DC%2BD38XktVGgtb0%3D 10.1093/jac/dkf008 12003967 (Pubitemid 34537634)
40. SM Uriarte RE Molestina RD Miller J Bernabo A Farinati K Eiguchi, et al. 2002 Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alpha J Infect Dis 185 1631 1636 1:CAS:528:DC%2BD38XkvFeguro%3D 10.1086/340575 12023769 (Pubitemid 34587525)
41. H Yamabe M Shimada M Kaizuka M Nakamura R Kumasaka R Murakami, et al. 2006 Roxithromycin inhibits transforming growth factor-beta production by cultured human mesangial cells Nephrology (Carlton) 11 524 530 1:CAS:528:DC%2BD2sXhvVams78%3D 10.1111/j.1440-1797.2006.00695.x (Pubitemid 44951234)